Journal: Pharmaceutics
Article Title: Design of the Multi-Bioactive Graphene-Oxide/Gelatin/Alginate Scaffolds as Dual ECM-Mimetic and Specific Wound Healing Phase-Target Therapeutic Concept for Advanced Wound Healing
doi: 10.3390/pharmaceutics17010089
Figure Lengend Snippet: ( a ) MRC5 cell viability in the presence of 12.50%, 25%, 50%, and 100% v / v of extracts of gelatin/alginate scaffolds reinforced with GO nanoparticles, ( b ) Photographs of plates with E. coli , gelatin/alginate scaffolds reinforced with GO nanoparticles after C. elegans were added, ( c ) Measurement of worms after 24 h using SenseCell Olympus program, ( d ) Percentage of body length of worms relative to control.
Article Snippet: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) reduction assay was then performed using human lung fibroblasts MRC5 cell line obtained from ATCC.
Techniques: Control